Blood-Brain Barrier Technologies and Global Markets

BCC Research
March 1, 2011
144 Pages - SKU: WA6077094
Countries covered: Global

The global market for blood-brain barrier (BBB) technology for therapeutics amounted to $12.3 million in 2010 and will reach $387 million by 2015, a compound annual growth rate (CAGR) of 99.3%.

The most common means of BBB passage or type of technology will be receptor-mediated transport (RMT), meaning crossing the BBB via certain receptors that include the insulin or transferrin receptors. This technology was valued at $12 million in 2010 and is expected to increase at a nearly 99% compound annual growth rate (CAGR) to reach $376 million in 2015.

The other technology to emerge as a vehicle for taking a drug across the BBB that otherwise could not cross it is carrier-mediated transport. This sector was valued at $0.2 million in 2010 and is expected to increase at a 121% compound annual growth rate (CAGR) to reach $10.5 million in 2015.


Additional Information

INTRODUCTION

STUDY GOALS AND OBJECTIVES

BCC’s goal in conducting this study was to determine the current status of the global therapeutic market for blood-brain barrier (BBB) technologies, including its growth potential over a 5-year period from 2010 to 2015. Our key objective was to present a comprehensive analysis of the current BBB technology and drug development market and its future direction with the aim to first define and classify that technology as it pertains to therapeutics in which the technology enables the therapeutic to directly cross rather than bypass the BBB.

REASONS FOR DOING THIS STUDY

BBB technologies are going to open up a vast untapped potential in the growing central nervous system therapeutic market where today growth is limited by the complexity of this layer in the brain that prevents the passage of many potentially useful molecules/compounds.

This report offers a picture of this technology potential that is on the verge of rapid increase. Therapeutics make up the main area of investment related to this technology; and, therefore, that is this report’s focus. BCC has not yet examined the BBB, although the central nervous system has been a consistent focus. As such, this snapshot and study of trending and growth is unique.

SCOPE OF REPORT

The scope of this study encompasses companies that develop technologies to enable the crossing of the BBB and drug development in which a quality of the development is enabling the crossing of the BBB in cases in which passage was previously impossible often due to size. BCC analyzes each technology, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next 5 years. Technological issues, including the latest trends, are discussed.

INTENDED AUDIENCE

In the report, BBB technology is described in terms of what it is and its history in medicine, the types and technology categories, major companies, impact on the pharmaceutical market, applications, current market values, growth potential, and significant trends. This study will be of interest to the biotechnology and pharmaceutical industries and related life science, analytics, drug discovery, and diagnostic test manufacturing companies as well as all those interested or actively working in drug and imaging agent research and investors in all of the above.

METHODOLOGY

BCC presents an analysis of the types of technologies, applications, and therapeutic areas representing financial value in the area of BBB technology in medicine as it relates primarily to drug discovery, development, and commercialization. Estimated values are based on actual aggregate sales for the years discussed. Information, in general, is compiled through a combination of primary and secondary research, including annual reports and interviews with company officials.

More CNS/Neurology reports by BCC Research

Neurostimulation: Technologies and Global Markets by BCC Research
Neurostimulation: Technologies and Global Markets The global neurostimulation devices market is expected to reach $3.8 billion in 2013 and $4.1 billion in 2018, with a ...
Histone Deacetylase Inhibitors: Emerging Markets by BCC Research
Histone Deacetylase Inhibitors: Emerging Markets The global histone deacetylase inhibitor (HDI) market reached $153 million in 2011 and $223.2 million in 2012. This market is ...
Nanomaterials in Theranostics: Global Markets by BCC Research
Nanomaterials in Theranostics: Global Markets provides: An overview of the global market for nanomaterials in medicine used for both therapy and diagnostics, or theranostics. ...
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets by BCC Research
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets - This report provides: An overview of the global market for central nervous system (CNS) biomarkers, ...
See all reports like this >>

More Global CNS/Neurology reports

Partial Seizure Global Clinical Trials Review, H2, 2014 by GlobalData
Partial Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, H2, 2014 provides data on the Partial Seizure ...
Generalized Seizures Global Clinical Trials Review, H2, 2014 by GlobalData
Generalized Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Generalized Seizures Global Clinical Trials Review, H2, 2014 provides data on the Generalized Seizures ...
Phobia Global Clinical Trials Review, H1, 2014 by GlobalData
Phobia Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Phobia Global Clinical Trials Review, H1, 2014 provides data on the Phobia clinical trial scenario. ...
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014 by GlobalData
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014 provides data on the Guillain-Barre Syndrome ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 6,650  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!